Skip to content

Author

Qianyu Chen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Organophosphate Flame Retardants Exposure Disrupts Serum Lipid Metabolism and Induces Hepatotoxicity: Evidence from the Population and Mouse Model.

Organophosphate flame retardants (OPFRs) are emerging pollutants that pose increasing health risks. The association between urinary metabolites of OPFRs (m-OPFRs) and lipid metabolism remains unclear. This study evaluated lipid metabolism disorders of OPFRs in a population-based observational study and C57BL/6 mice. Urinary m-OPFRs, serum lipid molecules, and biochemical biomarkers in serum were measured. Linear regression and quantile-based g-computation analyses assessed associations between m-OPFRs and lipid markers. Benchmark dose and 95% lower confidence limit (BMDL) for m-OPFRs were determined by Bayesian BMD analysis, and the health risk of internal exposure was further assessed by hazard quotient (HQ). Mediation analysis assessed whether lipid molecules mediated OPFRs-induced hepatotoxicity. Association analyses identified three m-OPFRs, including bis(1-chloro-2-propyl) phosphate (BCIPP), diphenyl phosphate (DPP), and bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), which were significantly associated with the levels of docosahexaenoic acid, 18:0 choline phosphate (LysoPC (18:0)), and 18:0 phosphoethanolamine. The BMDLs of BCIPP, DPP, and BDCIPP were 1.320, 0.100, and 0.030 μg/L, respectively. BDCIPP showed the highest HQ (4.50), followed by BCIPP (2.30) and DPP (0.66), indicating that the non-cancer risk of BDCIPP should be of concern. TDCIPP exposure induced hepatotoxicity in mice. LysoPC (18:0) increased at early exposure and mediated 7.88-30.02% of hepatotoxicity (P < 0.05). In conclusion, TDCIPP may induce hepatic lipid toxicity.

Meiyu Zhou, R. Tian, Jialei Zhu et al. · 0 citations
Open access Aug 2026

Serum synthetic phenolic antioxidants, transformation products, and thyroid homeostasis in adults from eastern China: Association and benchmark dose assessment.

Although toxicological studies suggest that synthetic phenolic antioxidants and their transformation products (SPAs/TPs) may disrupt thyroid function, epidemiological evidence and exposure safety thresholds remain limited. This study included 810 adults from Jiangsu Province, China, and measured serum concentrations of 12 SPAs, 3 TPs, and 7 thyroid function indicators (TFIs). Multiple linear regression (MLR) and restricted cubic spline (RCS) analyses were used to evaluate associations between individual SPAs/TPs and TFIs, whereas quantile g-computation (qgcomp) and Bayesian kernel machine regression (BKMR) were applied to assess the joint effects of mixed exposure. In addition, the Benchmark Dose Software (BMDS) was used to estimate the benchmark dose (BMD) and its lower confidence limit (BMDL) for serum SPAs/TPs, and to derive the corresponding reference doses (RfDs). The results showed widespread exposure to multiple SPAs/TPs among the study participants. Both individual and mixed exposure to SPAs/TPs were significantly associated with increased levels of free thyroxine (FT4) and total triiodothyronine (T3), as well as decreased levels of thyroid-stimulating hormone (TSH) and the T4/T3 ratio. Among the detected compounds, BHT-COOH (3,5-di-tert-butyl-4-hydroxybenzoic acid) and AO245 (triethylene glycol bis(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate) were the primary contributors to elevated FT4 and T3 levels. Under a benchmark response (BMR) of 5%, the estimated RfDs were 0.018 mg/kg/day for BHT-COOH and 0.181 mg/kg/day for AO245, and potential health risks may exist (HQc > 1). This study is the first to evaluate the effects of exposure to SPAs/TPs on thyroid homeostasis, providing a scientific basis for the formulation and improvement of targeted regulatory policies.

Jun Huang, Yueming Ren, Wenyuan Lu et al. · 0 citations